#Sustainability #Sweden #Gothenburg #Annual Report #Getinge

Getinge's Annual Report 2025: A Year of Resilience and Innovation

Introduction
On March 26, 2026, Getinge presented its Annual Report for the year 2025, which notably included a Sustainability statement reflecting the company’s commitment to responsible business practices. This report illustrates how the firm navigated through a turbulent geopolitical climate and the resulting economic ramifications, including heightened costs related to tariffs and fluctuating currency exchange rates.

Financial Performance Overview
Getinge reported a remarkable net revenue of SEK 35 billion for 2025 characterized by organic growth across all its operational sectors. Despite facing extensive challenges influencing its financial outcomes—such as tariffs and currency fluctuations that accumulated over SEK 1 billion—the company successfully maintained an unchanged adjusted EBITA margin throughout the year. This achievement serves as a testament to the robustness of Getinge’s business model and its enhanced operational resilience.

Mattias Perjos, President and CEO, commented on the year: "2025 was a year in which our strategy, global presence, and ways of working were truly tested—and proved their strength. We delivered steady results amid a more complex external environment, reached crucial regulatory milestones, and fortified our standing in prioritized markets."

Regulatory Compliance and Innovations
Throughout the year, Getinge achieved noteworthy advancements in both quality and regulatory compliance. A significant milestone was the reinstatement of the CE certificate for their intra-aortic balloon pump, Cardiosave, alongside multiple new Medical Device Regulation (MDR) approvals. Moreover, the launch of various new products focusing on intensive care, surgical workflows, and life sciences emphasized Getinge's priority towards enhancing productivity, patient safety, and sustainable resource utilization.

The demand for efficient and sustainable healthcare solutions is on the rise due to shifting demographics, resource scarcity, and mounting pressure on healthcare systems globally. In response, Getinge rolled out a broad array of offerings and fostered collaborations with customers, introducing solutions designed to enhance workflows while reducing environmental impact.

Long-Term Vision
Getinge remains steadfast in its long-term strategic direction, underscored by a commitment to quality, continuous innovation, and solid customer partnerships. The CEO reiterated, “We continue to build on a strong foundation for profitable growth and long-term value creation.”

Financial Stability and Dividend Proposal
Another key highlight in the report was Getinge's strengthened financial stance, marked by reduced net debt and a solid equity ratio. Following these positive results, the Board of Directors has recommended a dividend payment of SEK 4.75 per share for the financial year 2025, further demonstrating Getinge’s commitment to delivering shareholder value.

Conclusion
Getinge's Annual Report for 2025 serves as a comprehensive reflection of the company's performance in the face of adversity, detailing its financial achievements and sustainability efforts. Available on Getinge's official website, the report encapsulates a year marked by resilience, strategic progression, and a collective effort towards better health solutions worldwide. With a workforce of approximately 12,000 employees and products sold in over 135 countries, Getinge remains dedicated to enhancing clinical results and optimizing workflows within hospitals and life science institutions.

For further inquiries, you can reach out to David Kördel, Head of Investor Relations, at +46 (0)10 335 0077 or email him at [email protected]
For media inquiries, contact Caroline Örmgård, Head of Media Relations, at +46 (0)10 335 0041 or email [email protected].